Skip to main content
padlock icon - secure page this page is secure

Open Access p38Cancer - Signal integration and rewiring during tumor development - ERC

Download Article:
 Download
(PDF 158.6 kb)
 
Cell fate decisions rely on signaling pathways that integrate external signals to coordinate specific intracellular programs. One of these pathways leads to the activation of the protein kinase p38a, which plays key roles in cell responses to many types of stresses as well as chemotherapeutic agents and oncogenes. Importantly, p38a acts in a cell context and cell type-specific manner to integrate signals that affect cell proliferation, differentiation and survival. There is good evidence indicating that p38a can negatively regulate tumor initiation at different levels. Intriguingly, recent results suggest that p38a activation might sometimes contribute to tumorigenesis. The molecular basis for the different functions of p38a are not well understood but it is likely that the network of substrates phosphorylated by p38a plays a major role. This project proposes to investigate mechanisms of signal integration by p38a with special emphasis on the re-wiring of this signaling pathway to serve oncogenic functions in cancer cells. An important part of the studies focuses on the mechanisms underlying pro-tumorigenic functions of p38a signaling, including the regulation of survival, proliferation and spreading of cancer cells. Our experimental approach combines the genetic manipulation with the use of chemical inhibitors in different mouse models and human cancer cell lines. We will also use genetically modified mice that allow the deletion of p38a in a cell type-specific manner to investigate in vivo functions of this signaling pathway during tumorigenesis, as well as how the p38a pathway regulates the interplay between tumor cells and different cell types in the tumor stroma. Taken together, this project is posed to open unique opportunities for exploration of how complex signaling networks integrate during tumor development. The results of the proposed work should provide a rationale to develop novel cancer therapies based on the use of currently available drugs that target the p38a signaling network.
No References for this article.
No Supplementary Data.
No Article Media
No Metrics

Keywords: CANCER CELL REGULATION; CANCER THERAPY; KINASE; MOUSE MODEL; P38 MAPK; SIGNALLING PATHWAY; TUMOR DEVELOPMENT; XENOGRAFT

Document Type: Research Article

Publication date: February 1, 2017

More about this publication?
  • Impact is a series of high-quality, open access and free to access science reports designed to enable the dissemination of research impact to key stakeholders. Communicating the impact and relevance of research projects across a large number of subjects in a content format that is easily accessible by an academic and stakeholder audience. The publication features content from the world's leading research councils, policy groups, universities and research projects. Impact is published under a CC-BY Creative Commons licence.

  • Subscribe to this Title
  • Terms & Conditions
  • Disseminating research in Impact
  • Information about Impact
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more